The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study

ConclusionTreatment with EBR in combination with GZR for 12 weeks is effective and well tolerated in Japanese patients with chronic HCV infection.ClinicalTrials.gov identifierNCT02203149.

http://link.springer.com/10.1007/s00535-016-1285-y

Source: Journal of Gastroenterology - November 20, 2016 Category: Gastroenterology Source Type: research